Improving Nefiracetam Dissolution and Solubility Behavior Using a Cocrystallization Approach

Buol, Xavier;Robeyns, Koen;Caro Garrido, Camila;TUMANOV, Nikolay;Leyssens, Tom;et.al.
(2020) Pharmaceutics — Vol. 12, n° 7, p. 653 (2020)

Files

pharmaceutics-12-00653-v2.pdf
  • Open Access
  • Adobe PDF
  • 4.17 MB
Download

Details

Authors
Show more
Abstract
In this work, we are the first to identify thirteen cocrystals of Nefiracetam, a poor water-soluble nootropic compound. Three of which were obtained with the biocompatible cocrystallization agents citric acid, oxalic acid, and zinc chloride. These latter have been fully structurally and physically characterized and the solubility, dissolution rate, and stability were compared to that of the initial Active Pharmaceutical Ingredient (API).
Affiliations

Citations

  • APA
  • Chicago
  • FWB

Buol, X., Robeyns, K., Caro Garrido, C., TUMANOV, N., Collard, L., Wouters, J., & Leyssens, T. (2020). Improving Nefiracetam Dissolution and Solubility Behavior Using a Cocrystallization Approach. Pharmaceutics, 12(7), 653. https://doi.org/10.3390/pharmaceutics12070653 (Original work published 2020)